Forte Biosciences (FBRX) IV elevated into data

Forte Biosciences (NASDAQ: FBRX) September call option implied volatility is at 410, October is at 310; compared to its 52-week range of 87 to 365 into the expected release of FB-401 Phase 2 data in Atopic Dermatitis. Call put ratio 1 call to 1.1 puts.

You May Also Be Interested In

• Apple (AAPL) call put ratio 1.4 calls to 1 put
• CAE, Inc. (CAE) 10900 contracts of July 30 calls trade
• Apple (AAPL) call put ratio 1.7 calls to 1 put amid wide price movement